Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease
- 1 December 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 76 (17) , 1259-1265
- https://doi.org/10.1016/s0002-9149(99)80353-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- 707-4 The Randomized Aldactone Evaluation Study (RALES): Parallel Dose Finding TrialJournal of the American College of Cardiology, 1995
- Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1993
- Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failureAmerican Heart Journal, 1993
- Anti-Aldosterone Treatment and the Prevention of Myocardial Fibrosis in Primary and Secondary HyperaldosteronismJournal of Molecular and Cellular Cardiology, 1993
- Aldosterone reduces baroreceptor discharge in the dog.Hypertension, 1992
- Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1988
- COMBINED SPIRONOLACTONE AND CONVERTING‐ENZYME INHIBITOR THERAPY FOR REFRACTORY HEART FAILUREAustralian and New Zealand Journal of Medicine, 1986
- Captopril in heart failure. A double blind controlled trial.Heart, 1984
- Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscleLife Sciences, 1982
- Ectopic arrhytmia provoking action of aldosteroneLife Sciences, 1962